Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.55%
1,100.22
-6.14
-0.55%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.47%
613.18
+2.89
+0.47%
—610.29610.29616.60610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.76%
1,220.41
+9.19
+0.76%
—1,211.221,211.011,221.341,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.24%
1,754.87
+4.16
+0.24%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.51%
631.38
+3.21
+0.51%
—628.17629.38634.09629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.54%
859.17
+4.60
+0.54%
—854.57855.71860.09855.45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.40%
216.01
-0.86
-0.40%
—216.87216.87217.79216.13——
SIXT
Technology
SIXT
Technology
SIXT
+1.08%
3,600.40
+38.46
+1.08%
—3,561.943,571.443,628.583,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.02%
903.45
+0.14
+0.02%
—903.31903.26906.56901.18——
SIXV
Health care
SIXV
Health care
SIXV
-0.04%
1,480.99
-0.55
-0.04%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.29%
2,406.91
+6.96
+0.29%
—2,399.952,404.452,418.812,398.09——
TBPH:NASDAQ
Theravance Biopharma Inc
$16.59
-0.48%
(-0.080) 1D
May 14, 1:34:59 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TBPH...
Open
$16.79
High
$16.80
Low
$16.48
Mkt. cap
855.26M
Avg. vol.
369.09K
Volume
135.77K
P/E ratio
7.53
52-wk high
$21.03
52-wk low
$8.40
EPS
$2.20
Beta
0.19
Shares outstanding
51.55M
No. of employees
90
News stories
From sources across the web
About Theravance Biopharma Inc
CEO-
Employees90
Founded2013
Headquarters-
SectorPharmaceutical industry
Websitetheravance.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
26.20M
19.99M
45.89M
17.70M
Cost of goods sold
10.49M
8.11M
7.36M
5.83M
Cost of revenue
10.49M
8.11M
7.36M
5.83M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.43M
18.33M
18.52M
17.72M
Operating expense
18.43M
18.33M
18.52M
17.72M
Total operating expenses
28.92M
26.44M
25.88M
23.55M
Operating income
-2.72M
-6.46M
20.01M
-5.85M
Other non operating income
75.14M
-
-75.14M
-
EBT including unusual items
73.21M
-2.89M
73.07M
-6.47M
EBT excluding unusual items
73.21M
-2.89M
-52.07M
-2.84M
Income tax expense
18.37M
-6.50M
12.04M
-1.54M
Effective tax rate
25.09%
225.13%
16.48%
23.76%
Other operating expenses
-
-
-
-
Net income
54.84M
3.62M
61.02M
-4.93M
Net profit margin
209.33%
18.08%
132.98%
-27.87%
Earnings per share
-0.08
0.04
0.06
0.01
Interest and investment income
1.46M
4.14M
3.74M
3.01M
Interest expense
-663.00K
-573.00K
-582.00K
-
Net interest expenses
794.00K
3.57M
3.16M
3.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.32M
-6.05M
20.41M
-5.47M
Gain or loss from assets sale
35.00K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer